SonoThera will be sharing our latest data at #ESGCT2024! Really wonderful to see our team's accomplishments presented to a wide audience. If you're in Rome at ESGCT, please, stop by!
We're thrilled to participate in #ESGCT2024 in Rome, where SonoThera will be presenting new data on our innovative nonviral, ultrasound-mediated gene therapy platform. Our latest research highlights the promising potential of our alternative gene therapy delivery platform in addressing the diseases of Hemophilia A and X-linked AIport Syndrome (XLAS). #sonothera #nonviral #innovation #HemophiliaA #AlportSyndrome #genetherapy #ESGCT2024